NCT00161980View on ClinicalTrials.gov

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2001

Study Completion Date

December 31, 2002

Conditions
Breast CancerLumpectomyMastectomy Plus Axillary Lymph Node DissectionLymphatic Leakage
Interventions
DRUG

Fibrin Sealant VH S/D

PROCEDURE

Surgical intervention alone without Fibrin Sealant VH S/D application

Trial Locations (8)

1090

Allgemeines Krankenhaus der Stadt Wien, University Clinic for Gynecology, Vienna

3100

Landeskrankenhaus St. Pölten, Sankt Pölten

16132

Istituto Nationale per la Ricerca sul Cancro, Genova

35062

Centre Régional de Lutte Contre le Cancer, Centre Eugène Marquis, Rennes

72076

Universitätsklinikum Tübingen, Frauenklinik, Tübingen

80337

Ludwig-Maximilians-Universität, Munich

95100

S. Luigi - S. Curro, Presidi Ospedalieri Unificati, Catania

97080

Universitätsklinikum - Frauenklinik, Würzburg

All Listed Sponsors
lead

Baxter Healthcare Corporation

INDUSTRY

NCT00161980 - Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites | Biotech Hunter | Biotech Hunter